Nimesulide + SerratiopeptidaseThird Party Manufacturing in India

The combination of Nimesulide and Serratiopeptidase works by targeting both the inflammatory cascade and tissue swelling simultaneously.

Nimesulide selectively inhibits COX-2, reducing pain and inflammation. Serratiopeptidase, a powerful proteolytic enzyme, breaks down abnormal proteins, bradykinin, and fibrin at the site of inflammation, which reduces swelling, improves microcirculation, and accelerates tissue repair. This dual biological effect helps the body recover faster from traumatic injuries, surgical wounds, and severe inflammatory conditions.

Unlike standard analgesics, this combination specifically addresses edema and promotes the natural healing process alongside rapid pain relief.

Therapeutic Uses

Nimesulide + Serratiopeptidase is prescribed for the treatment of:

• Post-operative inflammation and pain: To reduce swelling and provide pain relief after surgical and dental procedures.
• Traumatic injuries: Such as severe sprains, strains, and fractures where localized edema is prominent.
• ENT infections: As adjunctive therapy in sinusitis, tonsillitis, or pharyngitis to reduce mucosal swelling and facilitate drainage.

Why Manufacturers Choose Nimesulide + Serratiopeptidase

The combination of an NSAID with a proteolytic enzyme is a highly effective and popular therapeutic approach in the Indian market for managing traumatic and post-operative inflammation. It commands a premium in the pain management segment due to its superior efficacy in resolving edema.

This makes the Nimesulide and Serratiopeptidase combination one of the most sought-after formulations for third party manufacturing in India, with consistent demand from orthopaedic, surgical, and general physician PCD franchise operators.